These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19277229)

  • 1. The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies.
    Flach AJ
    Trans Am Ophthalmol Soc; 2008; 106():138-45; discussion 145-8. PubMed ID: 19277229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of eyelid closure and nasolacrimal duct occlusion on the systemic absorption of ocular timolol in human subjects.
    Kaila T; Huupponen R; Salminen L
    J Ocul Pharmacol; 1986; 2(4):365-9. PubMed ID: 3503120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New technique to reduce systemic side effects of timolol eye drops: The tissue press method-Cross-over clinical trial.
    Müller L; Jensen BP; Bachmann LM; Wong D; Wells AP
    Clin Exp Ophthalmol; 2020 Jan; 48(1):24-30. PubMed ID: 31525271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to glaucoma drug delivery.
    Ghate D; Edelhauser HF
    J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial.
    Maul EA; Friedman DS; Quigley HA; Jampel HD
    Br J Ophthalmol; 2012 Feb; 96(2):250-3. PubMed ID: 21515561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the therapeutic index of topically applied ocular drugs.
    Zimmerman TJ; Kooner KS; Kandarakis AS; Ziegler LP
    Arch Ophthalmol; 1984 Apr; 102(4):551-3. PubMed ID: 6704011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review.
    Yee RW
    Curr Opin Ophthalmol; 2007 Mar; 18(2):134-9. PubMed ID: 17301615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing anatomical pattern of topical anti-glaucoma medications associated lacrimal obstruction with a control group.
    Kashkouli MB; Pakdel F; Hashemi M; Ghaempanah MJ; Rezaee R; Kaghaz-Kanani R; Ahadian A
    Orbit; 2010 Apr; 29(2):65-9. PubMed ID: 20394542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side effects of glaucoma medications.
    Detry-Morel M
    Bull Soc Belge Ophtalmol; 2006; (299):27-40. PubMed ID: 16681086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical drug delivery to the eye: dorzolamide.
    Loftsson T; Jansook P; Stefánsson E
    Acta Ophthalmol; 2012 Nov; 90(7):603-8. PubMed ID: 22269010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Punctal occlusion and topical medications for glaucoma.
    Huang TC; Lee DA
    Am J Ophthalmol; 1989 Feb; 107(2):151-5. PubMed ID: 2913809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic side effects from ophthalmic timolol and their prevention.
    Fraunfelder FT; Meyer SM
    J Ocul Pharmacol; 1987; 3(2):177-84. PubMed ID: 3503912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentration of topically applied betaxolol in elderly glaucoma patients.
    Vainio-Jylhä E; Vuori ML; Pyykkö K; Huupponen R
    J Ocul Pharmacol Ther; 2001 Jun; 17(3):207-13. PubMed ID: 11436941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Jefferys JL; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):845-50. PubMed ID: 24831037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administration.
    Holló G; Whitson JT; Faulkner R; McCue B; Curtis M; Wieland H; Chastain J; Sanders M; DeSantis L; Przydryga J; Dahlin DC
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):235-40. PubMed ID: 16384968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion.
    Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
    Am J Ophthalmol; 1992 Jul; 114(1):1-7. PubMed ID: 1621773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Surface Disease and Glaucoma Medications: A Clinical Approach.
    Zhang X; Vadoothker S; Munir WM; Saeedi O
    Eye Contact Lens; 2019 Jan; 45(1):11-18. PubMed ID: 30199425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.